AAMC submitted a letter May 7 to the Department of Health and Human Services (HHS) Office for Human Research Protections (OHRP) on the proposed issuance of a harmonized guidance on electronic informed consent by OHRP and the Food and Drug Administration (FDA).

AAMC submitted a letter May 7 to the Food and Drug Administration (FDA) on the draft guidance for industry, clinical investigators, and institutional review boards for the use of an electronic informed consent in clinical investigations.

Several members of the Federation of Associations of Schools of the Health Professions (FASHP) sent an April 30 joint letter to House and Senate Education Committee leadership on the Department of Education’s state authorization regulation and its impact on clinical training across state lines.

The AAMC joined eight fellow hospital and health systems in a letter to Congress opposing the inclusion of Medicare sequestration cuts to offset the cost of the Trade Adjustment Assistance (TAA) program.

The AAMC submit a letter to the FDA regarding areas of public health concern for racial/ethnic minority populations to enhance development of the FDA’s research agenda and inform funding decisions for the next fiscal year.